Results 151 to 157 of about 2,233 (157)

Tezepelumab in eosinophilic granulomatosis with polyangiitis (EGPA)

Airway pharmacology and treatment
Alexandra Nanzer, Anne-Catherine Maynard-Paquette, Jessica Gates, Faizan Harris, Cris Roxas, Linda Green, Mariana Fernandes, Louise Thomson, Jodie Lam, Grainne D'Ancona, Claire Hopkins, Michelle Fernando, Tevfik Ismail, Jaideep Dhariwal, David Jackson   +14 more
openaire   +1 more source

Population Pharmacokinetic Modeling and Exposure–Efficacy and Body Weight–Response Analyses for Tezepelumab in Patients With Severe, Uncontrolled Asthma

Journal of Clinical Pharmacology
Angelica L Quartino, Yanan Zheng, Gene Colice   +2 more
exaly  

Tezepelumab in patients with allergic and eosinophilic asthma

Allergy: European Journal of Allergy and Clinical Immunology
Ian D. Pavord, Marek Lommatzsch, Andrea Matucci   +2 more
exaly  

Early response to Tezepelumab in type-2 severe asthma patients non-responders to other biological treatments: a real-life study

Journal of Asthma
Miguel Jiménez-Gómez
exaly  

Real-World Data on Tezepelumab in Patients With Severe Asthma in Germany

Journal of Allergy and Clinical Immunology: in Practice
Leonie Biener, Stephanie Korn
exaly  

Clarification of the efficacy of tezepelumab in the phase 2a COURSE trial

Journal of Allergy and Clinical Immunology
Dave, Singh, MeiLan K, Han, Jean-Pierre, Llanos, Neil, Martin, Amit, Parulekar, Konstantinos, Kostikas, Sandhia S, Ponnarambil   +6 more
openaire   +2 more sources

COURSE: Encouraging results for tezepelumab in COPD

Medicom Conference Report ATS 2024
openaire   +1 more source